Concepedia

Luz Jubierre

LJ

6

Publications

601

Citations

6

H-Index

2013

Active since

Affiliations

Vall d'Hebron Institut de Recerca(Current)

Icahn School of Medicine at Mount Sinai

Institut d'Investigació Biomédica de Bellvitge

New York University

Luz Jubierre is an author at Vall d'Hebron Institut de Recerca specializing in medicine, tumor biology, and cell biology.

Top concepts

MedicineCell BiologyTumor BiologyRadiation OncologyEpigeneticsCancer BiologyNon-coding RnaCancer ResearchSystems BiologyCancer Cell Biology

Publications per year

2013–2019

6

Publications

6

BRD4 Sustains Melanoma Proliferation and Represents a New Target for Epigenetic Therapy

Miguel F. Segura, Bárbara Fontanals-Cirera, Avital Gaziel‐Sovran et al. · Cancer Research · 2013 · 240 citations · Full text

Epigenetic Change, Cancer Biology, Epigenetics +19

ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures

Zulekha A. Qadeer, David Valle‐García, Dan Hasson et al. · Cancer Cell · 2019 · 114 citations · Full text

Ezh2 Inhibition, Neuro-oncology, Molecular Neuroscience +8

miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer

Andrea Feliciano, Yoelsis Garcia‐Mayea, Luz Jubierre et al. · Cell Death and Disease · 2017 · 103 citations · Full text

Cancer Stem Cell, Cancer Biology, Tumor Biology +16

BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways

Luz Jubierre, Aroa Soriano, Laura Planells‐Ferrer et al. · Oncogene · 2016 · 91 citations

Cell Regulation, Neuroblastoma Cell Viability, Cell Death +7

MicroRNA-497 impairs the growth of chemoresistant neuroblastoma cells by targeting cell cycle, survival and vascular permeability genes

Aroa Soriano, Laia París-Coderch, Luz Jubierre et al. · Oncotarget · 2016 · 34 citations · Full text

Rows per page

1–5 of 6